C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/4706 (2006.01) A61K 31/4709 (2006.01) A61P 11/00 (2006.01) C07D 215/54 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 407/12 (2006.01) C07D 407/14 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2526228
There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
L'invention concerne des nouveaux composés de formule (I) ou des sels de ceux-ci, acceptables au plan pharmaceutique, formule dans laquelle R1, R2, R19, R20 et R34 sont tels que décrits dans la spécification, leurs procédés de préparation, des formules les contenant et leur utilisation thérapeutiques pour le traitement de maladies inflammatoires.
Baldwin Ian Robert
Barker Michael David
Dean Anthony William
Eldred Colin David
Evans Brian
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Quinoline derivatives as phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as phosphodiesterase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2012428